STOCKS TELEGRAPH

Author: ST Staff

Why did Uxin Limited (UXIN) stock soar in the current trading session?

In the current market trading session, Uxin Limited (UXIN) stock soared by 7.03% to the price of $1.37 at the time of writing. UXIN stock closed Wednesday’s session at $1.28. The UXIN stock volume traded today at 13.53 million shares. The average daily volume for the past 3 months has been 12.12 million which shows that today’s share volume exchanged more hands. In the past year, UXIN stock fell by -15.79%. However, in the past week, the shares jumped by 3.23%. In the previous three and six months, the UXIN stock soared by 17.43% and 7.56% respectively. Furthermore, Uxin Limited currently has a worth in the market of $352.83 million and has 332.52 million outstanding shares.

The business platform and model of Uxin Limited

Uxin Limited is an investment holding company that specifically focused on operating an e-commerce website as a platform for buying and selling of used cars. It is considered China’s leading online used car dealer. Along with the selling of used cars, it also provides the services of car evaluation, value-added products for cars, supporting services all of which come under the Uxin Used Car brand.

The company also has an auctioning service under the name Uxin Auction which provides businesses and individual clients the opportunity and service for acquiring cars through online auctions. The third-party financing of cars for the buyers is also a service that Uxin facilitates for financing solutions and transaction services.

Recent updates and press-release by Uxin Limited

Today – 22^nd April 2021, Uxin Limited announced two updates regarding its financial operations as well as collaboration with a company.

Announcing the schedule for financial report release

Firstly, Uxin Limited announced that it will report its financial result for the year 2021 (fiscal year) on April 28, 2021. The financial report will specifically indicate the third quarter period of the fiscal year 2021 which ended on 31^st December 2020 and will be unaudited.

The management team will schedule a conference call before the U.S market opens on 28^th April 2021 – Wednesday at 8:00 am Eastern time.

Strategic partnership with JD.com

Furthermore, China’s leading online used car dealer also released today another press release, stating that it has entered into a strategic collaboration with JD.com. The aim of the partnership is to expand Uxin’s e-commerce presence for used cars through JD’s platform by developing an online store for used car transactions.

Consumers will find this site to be very convenient and easily accessible for the use of searching used cars and used car-related products and services. Both companies will provide a one-stop user car website which will have solutions like car inspection, aftersales services, and car insurance. Uxin and JD.com will access all the software, data and web applications for used car businesses including supply chains, inspection standards and data management.

April 22, 2021
Evlous Inc. (EOLS) plunged in the premarket trading session; here’s why

In premarket Evolus Inc. (EOLS) stock plunged by-16.36% to the price of $9.80 at the time of writing. EOLS stock closed the previous session at $11.72 to gain 11.09%. The EOLS stock volume traded today at 0.56 million shares. The average volume for the past 3 months has been 1.57 million. EOLS stock has soared by 176.42% for the past year. In the past three and six months, the EOLS stock soared by 102.42% and 179.71% respectively. Furthermore, The Evolus Inc. is currently valued at $526.58 million and has 33.75 million outstanding shares

What is the operational background of Evolusinc.?

Evolusinc. is a beauty performance company that specifically focuses on aesthetic-related products that are applied medically or surgically. The company sells these products to physicians and patients alike. The company’s product offering include Jeuveau which is the formula used for the non-permanent improvement in the aesthetics of adults that have moderate-severe glabellar lines. Jeuveau’s chemical composition includes 900 kilodalton purified botulinium toxic type A composition (prabotulinumtoxinA-xvfs) which is the first and only U.S Food and Drug Administration approved neurotoxin.

The platform that EOLS stock uses for its design and development of products is known as Hi-Pure^TM technology. The company aims to bridge the gap between medical aesthetics and customers that are in-need and demand such product services.

Announcement of underwritten public offering proposal

Evolus Inc. announced on 21^st April 2021, that it has initiated a proposal based on underwritten public offering. This underwritten offering is conditioned on the market situation as well as other subjections, under which it is proposing to issue and sell shares of its common stock. The aim of this underwritten public offering is to generate funds and gather enough capital to proceed further with the advancement and expansion in the growth of Jeuveau, general operational activities, and European pre-launch activities.

Evolus stock will consider in the public offerings, a grant for the underwriters of the offering in the form of an option to purchase up to an additional 15% of the EOLS stock shares from its common stock for a 30 days purchase period. The offering price is $9.50 per share and the total public offering shares are 9,000,000 of its common stock.

The EOLS stock S-3 form details

The shares of the EOLS stock to be all sold by Evolus, the company itself. The total proceeds from the offering are expected to be $85.5 million. However, the assurance for the completion of the offering is not determined. The underwritten public offering proposal will be complied only with the means of a prospectus supplement and accompanying prospect. All of this content is included in the Evlous registration statement which came in effect on 15^th April 2019 and is given on form S-3.

Outlook for the gross profit margin of EOLS stock

Previously the company had stated in its financial outlook that the Allergan/Metydoxand Daewoong settlement agreement (announced in February 2021 and March 2021) is expected to negatively impact Evolus’s gross profit margins through September 2022 after which it will return to normal levels as observed for the fiscal year 2020.

April 22, 2021
Predictive Oncology Inc. (POAI) stock rises on Wednesday‘s Aftermarket: Why is it so?

Shares of the Predictive Oncology Inc. (POAI) stock continued the rising momentum in yesterday’s aftermarket trading session after taking a gain of 14.27% at the previous closing. POAI stock price saw a push of 5.5% to reach $1.15 a share in the late hours of yesterday on April 21, 2021. The CEO of Predictive Oncology, Mel Engle has been featured in the latest episode of the Bell2Bell podcast. Let’s try to figure out how this podcast justifies the bullish sentiment.

Bell2Bell Podcast:

Investor Brand Network, a company that connects the public companies to the investment community, recently announced the latest episode of Bell2Bell podcast in which it featured newly appointed CEO of POAI stock Mel Engle along with CFO Bob Myers and Mark Collins, Chief Technical Officer of the POAI’s Helomics subsidiary. Mel Engle talked about his background and past experiences.

Mel Engle had been serving as the board member of POAI stock for the past four years and had been the Chairman of the board for the past one and half years. Before this experience, Mel had served as a CEO for many companies, and Day Laboratories is one of them which was the subsidiary of Merck. Mel confidently said in the podcast that he has enough experience in the research and development field and much exposure to Predictive Oncology’s current operations.

Discussion about POAI’s current financial standing:

The CFO Bob Myers discussed the current financial condition of the POAI stock and said that Predictive Oncology is in a great position in terms of its cash capability as well as strengthening its balance sheet. POAI stock has no liabilities and undergoing many operations in terms of the income which POAI stock would get in this year. Predictive Oncology is in a strong position to run its current projects.

Helomics Developments

Mark Collins updated about Helomics and said about its assets as a fee-for-service platform for various pharmaceutical companies in order to test their drugs against the cancer cell lines of Helomics. Collins further told the details about the development of the internal drug repositioning project which was started earlier this year.

Conclusion:

POAI stock is hot among investors as far as market sentiment is concerned after the announcement of the Bell2Bell podcast in which the CEO of POAI stock is featured. Remarks of the CEO and other officials of the Predictive Oncology show that the POAI stock growing day by day and is in a good position in terms of future revenue. Hence it can be a good bet for investors in the long run.

April 22, 2021
Why NeuBase Therapeutics, Inc. (NBSE) stock declined in Wednesday’s aftermarket?

Shares of the NeuBase Therapeutics, Inc. (NBSE) stock were declining in yesterday’s aftermarket trading session after the spread of the news that Neubase stock announced the proposed public offering of its common stock. NBSE stock price saw a downtrend of 9.17% to drop at $5.45 a share in the late hours of Wednesday on April 21, 2021. NBSE was green in the previous trading session and recorded a gain of 3.09% at closing. Let’s discuss the current events in detail.

What’s happening?

NeuBase Therapeutics, Inc is a pre-clinical stage pharmaceutical company mainly focused on the treatment of rare genetic diseases as well as cancers resulting from mutant genes through the development of various therapies.NBSE stock recently started the underwritten public offering of shares of its common stock. The proposed public offering is subjected to the market along with various other conditions and the actual size of the offering, and the completion date of it has not been disclosed by the NBSE stock. The underwriters will be granted the 30-day option for the purchasing of additional 15% shares of the common stock of NeuBase and the terms and conditions for this option would be similar to the terms and conditions of the public offering.

NeuBase stock intends to use the net proceeds from the proposed public offering in its general corporate purposes as well as working capital. Part of the proceeds will be used in the product candidates and pipeline expansion of NBSE stock.

Previous News of NBSE stock:

On April 08, 2021, NeuBase stock did the announcement that it will host the virtual R&DDay for investors and analysts on June 8, 2021, from 12:30 p.m. to 2:30 p.m. EDT.NBSE stock will present its new data and in-depth review of the development of pipeline candidate products of Huntington’s disease, myotonic dystrophy type 1, and the previously undruggable target in a new oncology program. The expansion of the management team will also be discussed in the event.

Conclusion:

Individuals are responding to the public offering announced by the NBSE stock. The completion date and the specific per-share price have not been assured in the offering. The upcoming event on June 8 will further clarify the position of NBSE stock.

April 22, 2021
Williams Industrial Services Group Inc (WLMS) stock soared in the recent trading session; here’s why
In the recent trading session, Williams Industrial Services Group Inc. (WLMS) stock soared by 20.19% to the price of $4.44 at the time of writing. WLMS previously closed Tuesday’s session at $3.72. The stock volume traded today at 2.35 million shares. The average volume of trade happening in the past 3 months is 94.53k which shows that today’s trade volume is exponentially high. In the past year, WLMS stock soared by 207.44%. In the past week, the shares slumped by -8.37%

Operational background of Williams Industrial Services Group

Williams industrial Services Group is an industrial machinery company that focuses on the services of construction and maintenance. It also provides construction-related maintenance, support, and modification for its clients. The company markets its services to companies like industrial end markets and the energy sector market.

William has its mission statement to be the on-first-basis provider of construction and construction-related specialty services. The company wants to aim on the commitment of high-quality performance, Thorough safety regulations, dedication to delivery, and providing value to customers.

Financial result of the full year and fourth quarter 2020

Williams industrial services group Inc. On 31st March 2021 announced the financial report of its fiscal fourth quarter ended on 31st December 2020. Overall, the company reported a decreased fourth-quarter revenue compared to the revenue of the fourth quarter 2019. However, the revenue for the full-year reporter increase compared to 2019. The company also reported a higher net loss in the fourth quarter 2020 compared to Q4 2019.

The CEO of Williams Tracy Pagliara stated an elated overall outlook of its performance in 2020 for its financial results. The CEO highlighted that the gross margins and cash liquidity from the operations generated significant capital profit and by refinancing the credit facilities the company had reduced its debt.

Q4 and FY 2020 highlights

Here are the highlights for the Q4 and full-year 2020:
1. WLMS generated a revenue of $64.1 million in Q4 2020 while it generated $66.8 million in the prior year.
2. WLMS posted $269.1 million revenue which is $23.3 million more compared to full-year 2029.
3. WLMS reported a net loss of $0.04 per share compared to $0.01 per share for Q4 2019.
4. WLMS had secured a net income of $2 million for full-year 2020 which is twice that of the full year 2019.
5. WLMS reported an EBITDA of $4 million for Q4 2020 compared to $4.2 million for Q4 2019.
6. WLMS had generated from its operating cash a total of $17.4 million in Q4 2020 and used it to refinance and clear the debt by $9.3 million.
Outlook of WLMS stock for the year 2021

For the year 2021, the company started with a stronger balance sheet and bolstered financial strength with which the company aims to diversify its operations and expand its product offerings. As the pandemic restrictions eased down and create more beneficial business activities and economic developments. WLMS stock aims to build its back lock throughout the rest of 2021. Furthermore, the company expects its interest expense in the balance sheet for fiscal 2021 to be approximately $1.5 million lower than in 2020.
April 21, 2021
Why Bionano Genomics, Inc. (BNGO) stock is rising today?

Bionano Genomics, Inc. (BNGO) announced today that the two large laboratories of the United Kingdom have adopted its Saphyr System for optical genome mapping after which the BNGO stock price saw a push of 3.72% to reach $5.58 a share at the time of this writing. BNGO stock went up in the previous closing by 2.09% with a $5.38 per share price. Let’s deep dive to explore more of it.

What’s happening?

Investors are responding to the recent news announced by Bionano stock today related to its Saphyr system adopted by two large laboratories in U.K. NHS Regional Genetics Laboratory in Belfast City Hospital and King’s College Hospital in London have adopted the Saphyr system of Bionano stock via its reagent rental program in which consumable are purchased over time subjective to the placement of the system. Both libraries are using the Saphyr System to diagnose heme malignancies through the timely identification of genomic structural variants of patients. The laboratory in Belfast will also use this system for various other rare and genetic diseases.

Recent Previous Activity:

BNGO stock on April 14, 2021, did announce the launching of an IRB-approved preclinical evaluation study by the Foundation for Embryonic Competence (FEC) pursuant to which FEC will use optical genome mapping (OGM) with the Saphyr system of Bionano stock in order to perform the analysis of genomes of couples who have gone through the repeated pregnancy loss or recurrent embryo implantation failure. The purpose of this study is to compare the performance of improved resolution of OGM with the traditional methods for the identification of structural rearrangement in connection with testing of embryos before implantation.

Financial View of BNGO stock:

In the fourth quarter of 2020, BNGO stock generated $4.0 million in revenue which represents a 43% increase as compared to the same period of 2019. The total fiscal revenue of 2020 was reduced to $8.5 million in 2020 from $10.1 million in 2019 due to limitations in laboratory operations by Bionano’s customers due to COVID-19.

Conclusion:

It seems that momentum was already built for the BNGO stock and its recent news has added more hype to the rising stock price. The recent developments show that the BNGO stock is growing day by day. Hence it can be a good bet for investors in the long run.

April 21, 2021
Fisker Inc. (FSR) jumped in the pre-market trading session; here’s why

In the pre-market trading session, Fisker Inc. (FSR) stock soared by 3.48% to the price of $13.38 at the time of writing. FSR stock jumped up to the price of $12.93 which is a 4.53% gain at its previous closed session. The FSR stock volume traded at 82.97 million shares. While the average volume of FSR shares is 18.66M for the past 3 months.

Fisker Inc.’s operational background

Fisker Inc. is an automotive company that focuses on developing and manufacturing one of the most luxurious and electric vehicles in the world as well as provide mobility solutions. The company’s headquarters is in Manhattan Beach, California. In the automotive industries, the company markets its automobiles as one of the most emotionally desirable cars that are also eco-friendly in their built. FSR stock focuses on the company’s vision of being driven to create a clean and sustainable future for everyone. Fisker Inc. also aims to become the number one e-mobility service provider in the automotive parts market and industry with its eco-friendly cars.

FSR stock surge and BofA’s “Buy” rating

Fisker Inc. has been seeing a surge in its stock performance and value since yesterday. This happened because the Bank of America announced on 20^th April 21, 2021, that it is initiating coverage for the analysis of the Fisker stock and has given a new rating of “Buy” for the stock- which led to the stock’s outperformance.

BofA analysis behind the “Buy” rating

Bank of America has an AutoTech entrant/SPAC analysis in which it has 10 criteria outlined. The automotive company that covers the majority of the criteria will gain a positive or “Buy” rating from the company. This is what happened with Fisker stock for which the BofA announced +6 out of the 10 requirements being met. BofA’s analyst John Murphy has given the stock a price target of $31. The company is in a competitively strong position due to its attractive offerings and has a very integrative platform for future expansion and partnerships. BofA believes specifically that FiskerInc has certain aspects like its go-to-market as well as the commercialization strategy which can be credited for having merits while at the same time the product offering is very compelling.

On 30^th March, FiskerInc participated in the Bank of America 2021 Virtual Global Automotive Summit. Henrik Fisker who is the chairman and chief executive officer of Fisker Inc. himself participated in the summit in its “Fireside Chat” program. He provided the audience update on the Fisker Ocean and Project PEAR. This participation in the Summit does suggest a hint that the works of BofA’s stock rating coverage may have been motivated after this summit and the CEO’s updates.

What investors need to keep in mind about the Electric Vehicle industry

However we need to realize that the EV market is becoming very concentrated and competitive, so the penetration becomes tough. However, that does not negate the volume growth seen in the electric vehicle industry. Companies that enter into this market are witnessing that the market has a Compound Annual Growth of +30%.

April 21, 2021
The TIMEs are Changing for the Crypto Sphere

TIME Magazine, one of the most circulated bi-weekly magazines in the US, is exploring the cryptocurrency sphere and its integration into blockchain technology. The magazine recently announced it is going to start accepting payments in cryptocurrencies. The magazine entered into a partnership with the digital asset exchange Crypto.com which now allows readers of the magazine to pay for subscriptions through digital assets.

The current bull run made it evident that cryptocurrencies are not mere speculative investments and blockchain technology holds a lot of potentials. This has led to various firms jumping in to explore the real-world use cases of blockchain technology while others have begun adopting cryptocurrencies.

TIME magazine recently sold three magazine covers as NFTs. However, For TIME magazine, the journey does not end over here. The magazine is extensively exploring non-fungible tokens and projects based around them. In an interview with Decrypt podcast, TIME magazine president Keith Grossman commented on the NFT sale that this is just the beginning of the journey.

Grossman stated that the magazine may soon shift from the NFT collectibles to NFTs for subscriptions and memberships. While other news outlets like The New York Times have also entered the NFT collectibles space, TIME is the first magazine to accept payments in cryptocurrencies and may soon integrate the NFT technology completely.

April 21, 2021
FuelCell Energy Inc (FCEL) plunged in the pre-market trading session; here’s why

In the pre-market trading session, FuelCell Energy Inc. (FCEL) stock plunged by-4.66% to the price of $8.19 at the time of writing. FCEL’s stock slumped to $8.59 in the previously closed session which is a -6.73% loss. The FCEL stock volume traded about 28.1 million shares. The average trade volume for the company in the past 3 months is 32.57M. In the past year, FCEL stock soared by 433.54%. In the past week, the stock slumped by -22.96%. In the past three and six months, the FCEL shares dropped by -52.61% and added 268.67% respectively. FuelCell Energy Inc. is currently valued at $2.71 billion with 312.11 million outstanding shares.

FuelCell’s operational portfolio

FuelCell Energy Inc is an energy-based company that specifically focuses on the provision of fuel cell based on technology and energy solutions. The company’s main operation includes design, operating, and selling services related to fuel cell power plant stationary for power production.

The company’s product offering includes SureSource which is a carbonate fuel cell technology for which it has established a product line. This product line includes utility grid, micro grid, carbon utilization and megawatt applications. It also provides natural gas pipeline applications through its power plant which are named SureSource Recovery.

The company is adamant for creating and generating energy based utilities such as useable heat, electricity and water through clean and efficient means. The company’s clientage includes the health sector, education sector, telecommunication, commercial independent power producers and government.

The company’s base of operation primarily exists in England, South Korea, Switzerland and Germany. The fuel cell industry as of recently has gainers and losers in the stock market.

The rise and fall in the stock performances of fuel cell companies

Company such as Plug power which is a hydrogen fuel based Energy Company as well as similar company named Bloom Energy has seen a gain in the Tuesday trading session however some of the competitors in the fuel cell industry have slumped in the same trading session.

Wells Fargo’s series of new ratings

What distinguishes these fuel cell companies are the news updated stock ratings for the industry. Specifically investment bank Wells Fargo announced on 19^th April that it has started covering Bloom Energy and has given it a rating of overweight which gave its stock performance a boost similarly Plug Power has been given an equal weight rating however it has outperformed In some of its operational portfolios which improved its stock value.

Reason behind FCEL stock performance slump

FuelCell energy on the other hand has been given by underweight rating by Wells Fargo which has lowered investors to lose some of their confidence in the stock. The reason for this analysis of downward growth trajectory is because the commercialization and marketing aspect of fuel cell is being surpassed by its competitors which gives it fewer competitive advantages and fewer incentives to make its stock look attractive.

April 21, 2021
Advantage Solutions Inc (ADV) stock plunged in the premarket; here’s why

In the premarket, Advantage Solutions Inc. (ADV) stock plunged by -6.52% to the price of $11.75 at the time of writing. ADV stock closed the previous session at $12.57 which is a loss of -2.33%. The ADV stock volume traded 0.26 million shares. The average volume of the stock traded for the past 3 months is 565.22k. For the past year, ADV stock soared by 13.24%. However, in the past week, it dropped down by -3.01%.

The operational background of Advantage Solutions Inc

Advantage Solutions is a sales and marketing services company that specifically focuses on outsourcing its expertise its sales and marketing services to clients. The company is deployed strategically in certain markets of Asia, Europe, Australia and Africa – here it employs its global scale services for the needs of MNCs. The company itself is headquartered in California and has offices spanning across North America.

This company has certain clients that belong to the consumer goods manufacturing and retail companies. ADV stock is an expert in its field and brings along high-quality insights along with high-class execution. The company executes multi-channel services that are inclusive of retail merchandising, e-commerce, business intelligence, and full suite of sales and marketing services through which it helps grow the customer demands and increase efficiency of operations along with other customized channels.

The recent activities that took place in the company

On 19th April 2021, Advantage Solutions Inc. announced that will release its first-quarter 2021 earnings report update which will take place after the market’s trading session closed on Monday on the date of 10^th May. Afterwards the company will hold a conference call which will take place after 5 pm on Monday the same day.

On 19^th March 2021, Advantage Solutions Inc. sent its team of management that had participated in the Summit of Jefferies Virtual Business Services. This Jefferies Virtual Business Services will as the name suggest, take place virtually.

Financial report for the fourth quarter and full 2020

Prior to the first quarter 2021’s earnings report, ADV stock released its financial report for the fourth quarter and full-year which ended on 31^st of December 2020.

The company overall faced a decline in its revenues. This was majorly due to the pandemic which caused a significant sector of the company’s business to be suspended or partially operating. However, there is some bright news as the company adjusted its operational strategy which allowed EBITDA to exceed the company’s expectation which had been set to $480-485 million after being revised from 475 million estimates. Now the actual adjusted EBITDA has delivered 487 million for the year 2020.

The highlight of the fourth quarter 2020 was such that the revenues had declined by $162.5 million to 850.4 million compared to the fourth quarter of 2019. Along with the adjusted EBITDA which was 132.5 million for Q4 2020 (decline of 8.2% from Q4 2019), the net loss was $138.9 million for the fourth quarter of 2020 compared to $153.7 million in 2019 Q4.

Expectation for the adjusted EBITDA 2021

As the restrictions of the pandemic and news of vaccine development has allowed the business to steadily return to full operation, the company has adjusted its EBITDA for the year 2021 to $515-$525 million compared to just $515 previously defined.

April 21, 2021